Medicare beneficiaries will not have to pay more than $2,000 per year for their medications, and beneficiaries with diabetes will not have to pay more than $35 per month for insulin, under the terms of...
Labor, enforcement trends creating operational, financial challenges for senior living
By
Kimberly Bonvissuto
Jul 22, 2022
Labor, behavioral health and the regulatory agenda are among the key 2022 trends that continue causing operational and financial challenges for senior living and other long-term care providers.
Leverage payment integrity solutions to ensure proper billing of telehealth services
By
Subrahmanyam Mantha
Jul 07, 2022
Don’t be surprised if the U.S. Department of Health and Human Services continues the COVID-19 public health emergency in mid-July, based on what government officials have said. If it ends, however, the...
So you want to manage more payment risk?
By
John O'Connor
Apr 28, 2022
Always remember this about risk management: the first word.
Medicare Advantage plans ‘robust’ at the expense of traditional Medicare plans: report
By
Kimberly Bonvissuto
Mar 17, 2022
Reducing payments to Medicare Advantage plans would ensure the sustainability of the Medicare program while maintaining access to popular plans that place a premium on quality care and preventive services,...
Feds delay ‘ticking time bomb’ set to invalidate existing health regulations
By
Kimberly Bonvissuto
Mar 07, 2022
The federal government once again is delaying implementation of a “ticking time bomb” that threatens to invalidate thousands of existing health regulations, including protections for older adults.
Medicare may rethink premium hike for pricey Alzheimer’s drug
Jan 10, 2022
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.
States don’t wait as fate of federal COVID vaccine mandates remains uncertain
By
Lois A. Bowers
Kimberly Bonvissuto
Jan 10, 2022
As employers wait to see whether the Supreme Court will issue stays against federal COVID-19 vaccine mandates from the Occupational Safety and Health Administration and Centers for Medicare & Medicaid...
Biogen cuts price of controversial Aduhelm in half
Dec 21, 2021
The drug shows promise in clearing the brain plaques believed to play a role in Alzheimer’s disease.
Federal COVID-19 vaccination, testing mandates have pros, cons, experts say
By
Kimberly Bonvissuto
Nov 05, 2021
Although generally supportive of federal COVID-19 vaccine mandates for members of its workforce, senior living leaders are concerned about the effects on its workforce.